MwanzoBLISSGVS • NSE
add
Bliss GVS Pharma Ltd
Bei iliyotangulia
₹ 163.84
Bei za siku
₹ 160.00 - ₹ 165.99
Bei za mwaka
₹ 92.15 - ₹ 172.42
Thamani ya kampuni katika soko
17.00B INR
Wastani wa hisa zilizouzwa
1.55M
Uwiano wa bei na mapato
27.15
Mgao wa faida
0.31%
Ubadilishanaji wa msingi
NSE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 2.18B | 2.74% |
Matumizi ya uendeshaji wa biashara | 682.58M | 6.38% |
Mapato halisi | 242.60M | -42.66% |
Kiwango cha faida halisi | 11.14 | -44.22% |
Mapato kwa kila hisa | — | — |
EBITDA | 414.11M | -23.69% |
Asilimia ya kodi ya mapato | 28.04% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 2.20B | 34.93% |
Jumla ya mali | 12.83B | 7.13% |
Jumla ya dhima | 2.34B | 0.06% |
Jumla ya hisa | 10.48B | — |
hisa zilizosalia | 105.02M | — |
Uwiano wa bei na thamani | 1.70 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 7.68% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 242.60M | -42.66% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Bliss GVS Pharma Limited is an Indian pharmaceutical company headquartered in Mumbai, India. Bliss GVS primarily develops, manufactures and markets products across various therapeutic categories including Anti-fungal, Contraceptive, Laxative, Anti-haemorrhoidal, Anti-spasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, Antipyretic, Analgesic and several others.
As of 31 March 2018, its market capitalization is INR 19.20 billion. Wikipedia
Ilianzishwa
1984
Tovuti
Wafanyakazi
831
